Roche Molecular Systems Senior PR Manager Salaries in Boulder | Comparably
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on read more
EMPLOYEE
PARTICIPANTS
15
TOTAL
RATINGS
176

Roche Molecular Systems Senior PR Manager Salaries in Boulder

The average Roche Molecular Systems Senior PR Manager in Boulder earns an estimated $117,260 annually. Roche Molecular Systems' Senior PR Manager compensation is $3,590 more than the US average for a Senior PR Manager.

In Boulder, The Communications Department at Roche Molecular Systems earns $35,150 more on average than the Business Development Department.

Last updated a year ago.

$57k
$76k
$91k
$108k
$156k
$223k
$252k
$117,260
Average Compensation
$117,260
avg. base

Senior PR Manager Salaries at Roche Molecular Systems

* estimated salary

Compensation at Roche Molecular Systems by Department

In Boulder, The Communications Department averages $35,150 more than the Business Development Department, and $431 less than the Enterprise Risk Department

Enterprise Risk
$186,671 Avg. total comp.
+$431
Communications
$186,240 Avg. total comp.
Business Development
$151,090 Avg. total comp.
-$35k

Senior PR Manager Compensation by Gender (All Companies)

The average female Senior PR Manager at companies similar size to Roche Molecular Systems reported making $134,358, while the average male Senior PR Manager at similar sized companies reported making $138,143.

Senior PR Manager Compensation by Ethnicity (All Companies)

The average Caucasian Senior PR Manager at companies similar size to Roche Molecular Systems reported making $134,560, while the average Hispanic or Latino Senior PR Manager at similar sized companies reported making $76,000.

How Senior PR Managers at Roche Molecular Systems Rate Their Compensation

The majority of Senior PR Managers at Roche Molecular Systems believe they're compensated fairly. 100% of Senior PR Managers at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems

×
Rate your company